ALS Flashcards

1
Q

is ALS a pure motor neuron disease?
A. True
B. False

A

B. False

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

why is ALS not considered as pure MN disease?

A
  1. 15% ALS patients - FTD
  2. 50% - subtle cognitive + behavioural dysfunction: emotional lability
  3. mutated genes - like TDP43 and C9, found in both ALS and FTD
    therefore, it is a spectrum with different range on scale with ALS and FTLD on the extreme ends and cases with both falling in between the range
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Name four prominent genes on ALS?

A
  1. SOD1
  2. TDP43
  3. FUS
  4. C9ORF72
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what type of mutations are usually seen in ALS ?

  1. Dominant
  2. Recessive
A
  1. Dominant
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

In ALS, 90% of cases are sporadic and 10% are familial?
A. True
B. False

A
  1. True
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what type of mutation takes place in

  1. SOD1
  2. TDP43
  3. C9
A
  1. SOD1 - dominant, missense (point mutation)
  2. TDP43 - point mutation
  3. C9 - repeat mutation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is the role of SOD1?

A
  • clears/removes all free radicals from the inter membrane space of mitochondria
  • acts like a free radical scavenger
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

why are free radicals harmful for the cell?

A

free radicals can cause

  1. DNA damage
  2. Protein alterations
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what happens to the mutant SOD1 in cytoplasm?

A
  • SOD1 is a sticky protein
    1. mutant SOD1 forms aggregates
    2a. aggregates + normal protein = increased ER stress -> shut down of protein synthesis until the problem is fixed or if not fixed -> cell death
    2b. the aggregates also interfere with normal protein (chaperones) folding resulting in decreased chaperone activity
    3. due to this even WT SOD1 starts misfolding
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

what happens to the mutant SOD1 in mitochondria?

A
  1. mutant SOD1 aggregate -> increased toxicity -> toxic interaction of mutant SOD1 with BCL2 resulting in
  2. increase BCL2 levels
    2a. interaction of Bcl2 and PTP = altered mitochondrial permeability (PTP) -> chemicals (CytC) leak out of the cell
    2b. decreased protein input through TOM (translocase of outer membrane)
  3. activation of apoptic pathway + cytochrome C -> cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

which are the proteins SOD1 aggregates interact with?

A
  1. chaperone proteins (cytoplasm)

2. Bcl2 (mitochondria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

what are the defects due to mutant SOD1?

A

axonal defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

explain the axonal defect due to SOD1 mutant?

A

Due to mtSOD1 NF form aggregate inclusions which impairs the axon transport
- It may also lead to neurite collapse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

what is HO, CHAT and NF-H?

A

HO - nuclear stain
CHAT - motor neuron stain
NF-H - neurofilament heavy chain
these are these are markers used in immunohistochemistry to study the axonal defect due to mtSOD1 in mtSOD1 MN and healthy MN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

what is the role of TDP43?

A
  1. normal pre-mRNA splicing

2. microRNA processing and transport

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

where is SOD1 found?

A

inter membrane space of mitochondria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

where is TDP43 found?

A

in the nucleus but also shuttles between nucleus and cytoplasm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

what are the downstream effects of mutant TDP43?

A
  1. pre-mRNA slicing - mutated TDP43 impairs the slicing function (unable to remove the introns)
  2. microRNA process and transport - impairs the biogenesis of microRNA and found everywhere in MN
  3. produces abnormal protein -> causes aggregation of stress granules and cellular contents -> sequestration of essential proteins-> cell death
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

what is microRNA ?

A
  • very short RNA

- regulate RNA by binding 3’UTR and inhibit translation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

what is found in C9 mutation of ALS?
A. Gain of function
B. Loss of function
C. both

A

C. both
Gain of function - toxic protein formation
Loss of function - inhibition of translation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

what are the downstream effects of mutant C9?

A
  1. decreased C9 translation -> decreased protein
  2. Formation of toxic RNA species
  3. Formation of toxic protein species
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

how many repeats of C9 are present in an healthy individual and ALS?

A

healthy individual - 25

ALS - 100-1000

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

how does mutant C9 cause nucleocytoplasmic transport defects?

A

C9 repeat expansion disrupt Ran gradient (GTP in nucleus to GDP in cytoplasm) and cause nucleocytoplasmic transport defects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

If >80% of ALS cases are sporadic, why bother studying familial mutations?

A
  1. there are few common genetic mutations in SALS and FALS
    1a. phosphorylated TDP43 inclusions
    1b. aggregation of cytoplasmic proteins
  2. FALS can be easily detected by tasing family history
25
Q

what are the advantages and disadvantages of ex vivo models (patient sample)?

A

Advantages
1. actual disease - closest you can get to the presentation of ALS in humans
Disadvantages
1. Post mortem changes
2. Expression affected by freezing conditions
3. detection - early detection of disease not possible
4. Cell type composition - may affect the results (the ratio of neurons differs between healthy and ALS individuals)
5. Genetic variation confounds results

26
Q

what are the advantages and disadvantages of in vivo models (animal samples) ?

A

Advantages
1. cell types - all relevant types are present
2. Possible to investigate adult neurons
Disadvantages
1. multiple copies of mutant protein - required to generate a phenotype; copies can get lost over generations
2. Mutant gene mouse model - displays sudden death instead of progressive death (death due to bowel obstruction)
3. Many drugs proven to be effective in in-vivo models (mouse models) but fail in human clinical trials; due to poor study designs or species-specific differences
4. Species specific differences confound results

27
Q

what are the advantages and disadvantages of in vitro models (cellular samples)?

A

Advantages
1. Compatible with large scale screening
2. Model investigates human cells (so no species-specific differences)
3. iPSCs can be formed into any cell
Disadvantages
1. Few cell types are included
2. iPSC derived neurons are largely foetal

28
Q

What is non-cell-autonomous effects?

A

when a cell displays a phenotype due to the mutation in genome of another cell

29
Q

Gives few examples of non-cell-autonomous effects

A
  1. astrocytes secrete toxic factors due to mutation in SOD1 and kill the cell, microglia and motor neuron
  2. SOD1 synthesis is silenced in microglia, astrocyte or oligodendrocytes
30
Q

which cells have shown non-cell-autonomous effects to contribute to motor neuron degeneration?

A
  1. microglia
  2. oligodendrocytes
  3. astrocytes
31
Q

what is the role of microglia and how does it exert its non-cell-autonomous effects in ALS?

A
  1. microglia - the innate immune cells of the nervous system become activated in all instances of ALS
    2a. synthesis of mutant SOD1 by microglia
    2b. mutant SOD1 may drive microglia to produce high levels of extracellular superoxide
  2. C9 inactivation -> abnormal microglia and age related neuroinflammation
32
Q

what is the role of oligodendrocytes (ODC) and how does it exert its non-cell-autonomous effects in ALS?

A
  1. the cells that myelinate the axons of upper MN and initial axonal segment of lower MN
  2. reduced mutant SOD1 in ODC maturation -> delayed disease onset
33
Q

what is the role of astrocytes and how does it exert its non-cell-autonomous effects in ALS?

A
  1. provides nutrients, buffering ions, recycling of the neurotransmitter glutamate and the final layer of blood brain barrier
  2. reduced mutant SOD1 in astrocytes -> delayed disease onset or progression
  3. mutated SOD1 impairs astrocytes function of glutamate uptake -> excitotoxicity -> cell death
34
Q

How does excitotoxicity play a role in motor neuron degeneration?

A
  1. glutamate release at synaptic cleft
  2. astrocytes take up these glutamate through GLAST and GLT1
  3. due to mutation -> astrocytes convert into reactive astrocytes
  4. reactive astrocytes -> block glutamate uptake -> increased levels of Ca2+, ROS, RNS -> excitotoxicity -> cell death
35
Q

Autophagy is increased in ALS

  1. True
  2. False
A

True

36
Q

is the increased autophagy beneficial or deleterious in ALS?

A

deleterious in ALS as it leads to the motor neuron degeneration

37
Q

What are the current approved therapies for ALS?

A

Riluzole and Edaravone - proved by FDA

38
Q

how does Riluzole work for ALS?

A

by suppressing excessive motor neuron firing (Every time neuron is fired the vesicles are released and Ach is released at the NMJ and that causes the muscle to contract)

39
Q

how does Edaravone work for ALS?

A

by suppressing oxidative stress (induced by mtSOD1 aggregates by interacting with chaperone proteins and TDP43 interacting with stress granules)

40
Q

what is cell-autonomous effect?

A

Cell displays a phenotype due to mutation in its own genome e.g. SOD1

41
Q

what are the defects at NMJ in ALS?

A
  1. reduction in pre and post-synaptic mitochondria compartments
  2. reduction of ChAT (MN marker protein) and synaptic vesicles
  3. Reduction in Acetylcholinesterase (AchE, breaks down Ach therefore, its reduction means more Ach resulting in excessive firing of MN)
42
Q

what is the difference b/w dying forward Vs dying back theory of ALS?

A

Starts from
1. Dying forward - motor cortex
2. Dying back - NMDA receptor
Mechanism involved
1. Dying forward - anterograde degeneration via glutamate excitoxicity
2. Dying back - retrograde transport due to deficiency of neurotrophic factors

43
Q

what are the differences between (a) animal models and (b) iPSC?

A
  1. (a) cells present in vivo conditions Vs (b) cells grown in 2D
  2. (a) all relevant cells types present Vs (b) few cell types included
  3. (a) adult neurone investigation possible Vs (b) iPSC largely foetal
  4. (a) species-specific differences confound results Vs (b) model investigates human cells
  5. (a) over expression of mutant protein Vs (b) physiological level expression of mutant protein
  6. (a) not compatible for large scale screening Vs (b) compatible for large scale screening
44
Q

what are the early clinical symptoms of ALS?

A
  1. weakness in legs and hands

2. difficulties with fine movements

45
Q

what are the late clinical symptoms of ALS?

A
  1. spasticity
  2. swallowing problems
  3. sensory symptoms ( may be due to lack of nutrition)
  4. eye movements preserved (ocular MN intact)
  5. autonomous functions maintained (HR, BR, urination etc)
46
Q

what is final stage of ALS post the early and late clinical symptoms?

A

intercostal regions blocked -> hypoxic -> respiratory failure

47
Q

what does the failure of upper and lower MN result in?

A

upper MN - muscle stiffness and spasticity

lower MN - spontaneous muscle twitching (fasciculations)

48
Q

what are the four types of mutation and its consequences?

A
  1. missense - incorrect AA may produce malfunctioning protein
  2. non sense - incorrect sequence causes shortening of protein
  3. insertion - incorrect AA may produce malfunctioning protein
  4. repeat expansion - repeated trinucleotides adds a string of glutamines (gin) to the protein
49
Q

what is the meaning of amyotrophic lateral sclerosis?

A

a-myo-trophic - no muscle nourishment

lateral sclerosis - scarring in the lateral column of spinal cord due to neurodegeneration

50
Q

what is the role of NMJ in ALS?

A

Every time neuron is fired the vesicles (filled with Ach/Ca2+?) are released and Ach is released at the NMJ and that causes the muscle to contract

51
Q

what causes contraction?

A
  • signal from somatic MN to limbic system

- release of Ach at NMJ

52
Q

where is upper and lower MN found?

A

upper MN - motor cortex

lower MN - brain stem + spinal cord

53
Q

what are the other names of ALS?

A
  1. Charcot disease

2. Lou-Gehrig’s disease

54
Q

what are the types of motor neuron disease?

A

there are 3 types:

  1. Spinal and Bulbar Muscular Atrophy (SBMA)
  2. Hereditary Spastic Paraplegia (HSP)
  3. Spinal Muscular Atrophy (SMA)
  4. ALS
55
Q

what is the difference between autosomal dominant vs recessive?

A

autosomal dominant - one mutant allele is enough to cause the disease
autosomal recessive - both mutant alleles are needed to cause the disease

56
Q

why there is decreased glutamate uptake in ALS syanptosome?

A

Decreased uptake of glutamate is due to the non cell autonomous activity of astrocyte as it fails to take up glutamate since it is inhibited via GLT and GLAST

57
Q

how is glutamate measured in ALS synaptosome?

A
  1. spinal cord tissue extracted -> homogenisation of synaptosome
  2. syanptosome + radioactive labelled -> measurement of gluatamate inside the synaptosome
58
Q

deletion of which of these leads to increased survival rate?

  1. MNs
  2. Microglia
  3. Astrocytes
  4. mutant SOD1
  5. All of them
A
  1. All of them